Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer

NCT04046185 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer Stage I

Interventions

DRUG: PD-1 inhibitor combined progesterone
DRUG: progesterone

Sponsor

Shanghai First Maternity and Infant Hospital